Drug profile · INN
hydrocortisone
HYDROCORTISONE VIATRIS 20
hydrocortisone (HYDROCORTISONE VIATRIS 20) is a glucocorticoid receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: for rx compounding. Current US regulatory status: approved.
Drug details — hydrocortisone
- US status
- approved
- Class
- Systemic hormonal preparations (H02)
- Route
- FOR RX COMPOUNDING
- Patents
- 5
- Programs
- 36
- Data quality
- 0.89
Quick answer
hydrocortisone (HYDROCORTISONE VIATRIS 20) is a glucocorticoid receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: for rx compounding. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12419831
Hydrocortisone oral liquid formulations
granted -
US 12133914
Hydrocortisone oral liquid formulations
granted -
US 11904046
Hydrocortisone oral liquid formulations
granted -
US 6803359
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
expired -
US 6319900
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
expired
Frequently asked questions
What is hydrocortisone?
hydrocortisone (HYDROCORTISONE VIATRIS 20) is a glucocorticoid receptor agonist. Associated with Alphapharm Pty Ltd. Route of administration: for rx compounding. Current US regulatory status: approved.
What is the brand name for hydrocortisone?
HYDROCORTISONE VIATRIS 20 is a marketed brand name for hydrocortisone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydrocortisone?
hydrocortisone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.